Phase 1 Ascites Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

AscitesOvarian Neoplasms Malignant

Cancer Institute and Hospital, Chinese Academy of Medical Sciences29 enrolled1 locationNCT07435701

Recruiting

Phase 1Phase 2

Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites

Ascites, MalignantCancer of Stomach, Adenocarcinoma

Qilu Hospital of Shandong University24 enrolled1 locationNCT06759064

Recruiting

Phase 1

Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics

Cirrhosis, LiverLiver FibrosisAscites Hepatic

PharmaIN74 enrolled9 locationsNCT05490888

Terminated

Phase 1

A phase Ia study of MRC202 in patients with malignant ascites caused by cancer.

Malignant ascites (hydoperitoneum) associated with cancer

MRC Biotech Pty Ltd12 enrolled1 locationACTRN12607000078459